TrialCancer chemotherapy and pharmacology2026
Longitudinal plasma phosphorylated neurofilament-heavy chain levels in oxaliplatin-induced peripheral neuropathy: a prospective multi-institutional exploratory study.
Yoshiharu Motoo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.